We are live on ! Find out more
RCM

Raleigh Capital Management Portfolio holdings

AUM $313M
1-Year Est. Return 23.55%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+23.55%
3 Year Est. Return
+71.82%
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
+$21.2M
Cap. Flow
+$5.43M
Cap. Flow %
2.82%
Top 10 Hldgs %
19.8%
Holding
915
New
76
Increased
369
Reduced
163
Closed
149

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.01M
2
CVX icon
Chevron
CVX
+$861K
3
XOM icon
ExxonMobil
XOM
+$817K
4
BMY icon
Bristol-Myers Squibb
BMY
+$696K
5
MRK icon
Merck
MRK
+$685K

Sector Composition

Rank Sector Weight
1 Financials 10.54%
2 Healthcare 10.29%
3 Consumer Staples 9.47%
4 Energy 7.21%
5 Utilities 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
526
TSMC
TSM
$2.18T
$5.83K ﹤0.01%
78
-2
-3% -$145
ANSS
527
DELISTED
Ansys
ANSS
$5.8K ﹤0.01%
24
+7
+41% +$1.63K
CIBR icon
528
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.3B
$5.78K ﹤0.01%
149
CBRL icon
529
Cracker Barrel
CBRL
$1.29B
$5.73K ﹤0.01%
60
-4
-6% -$417
XLI icon
530
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
$5.72K ﹤0.01%
58
OEF icon
531
iShares S&P 100 ETF
OEF
$20.5B
$5.65K ﹤0.01%
33
BF.B icon
532
Brown-Forman Class B
BF.B
$13.1B
$5.64K ﹤0.01%
86
MUSA icon
533
Murphy USA
MUSA
$9.61B
$5.59K ﹤0.01%
20
+10
+100% +$2.9K
GPK icon
534
Graphic Packaging
GPK
$3.58B
$5.56K ﹤0.01%
+250
New +$5.5K
SPTN
535
DELISTED
SpartanNash
SPTN
$5.49K ﹤0.01%
182
QTEC icon
536
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.76B
$5.47K ﹤0.01%
52
IONS icon
537
Ionis Pharmaceuticals
IONS
$9.4B
$5.44K ﹤0.01%
144
+72
+100% +$3.03K
PFBC icon
538
Preferred Bank
PFBC
$1.25B
$5.38K ﹤0.01%
72
+36
+100% +$2.62K
LNN icon
539
Lindsay Corp
LNN
$1.18B
$5.38K ﹤0.01%
33
+14
+74% +$2.31K
GATX icon
540
GATX Corp
GATX
$6.27B
$5.34K ﹤0.01%
50
+21
+72% +$2.19K
CI icon
541
Cigna
CI
$74.6B
$5.32K ﹤0.01%
16
UCB
542
United Community Banks
UCB
$4.28B
$5.29K ﹤0.01%
156
-661
-81% -$24K
FBT icon
543
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$5.24K ﹤0.01%
34
WIRE
544
DELISTED
Encore Wire Corp
WIRE
$5.23K ﹤0.01%
38
+17
+81% +$2.35K
EQC
545
DELISTED
Equity Commonwealth
EQC
$5.14K ﹤0.01%
206
+91
+79% +$2.33K
HASI icon
546
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
$5.07K ﹤0.01%
175
+35
+25% +$1.02K
INSP icon
547
Inspire Medical Systems
INSP
$1.74B
$5.04K ﹤0.01%
20
+12
+150% +$2.56K
HZNP
548
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.01K ﹤0.01%
44
GM icon
549
General Motors
GM
$76.8B
$4.99K ﹤0.01%
148
+54
+57% +$2K
EPI icon
550
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$4.99K ﹤0.01%
153

Similar funds

Raleigh Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Raleigh Capital Management held 915 positions worth $192M, up 12% from $171M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raleigh Capital Management's Q4 2022 filing shows 76 new, 369 increased, 163 reduced and 149 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M. The largest sale was Amgen, an estimated $1.01M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Raleigh Capital Management's largest Q4 2022 buy was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M.
  • Raleigh Capital Management added most to Medtronic in Q4 2022, an estimated $1.02M increase.
  • Raleigh Capital Management's biggest Q4 2022 reduction was Amgen, cutting an estimated $1.01M.
  • Raleigh Capital Management fully exited iShares Core High Dividend ETF in Q4 2022, selling an estimated $454K.
  • Raleigh Capital Management's ten largest holdings make up 20% of its $192M portfolio in Q4 2022.
  • Raleigh Capital Management opened 76 new positions and closed 149 in Q4 2022.
  • Raleigh Capital Management's portfolio value rose 12% quarter-over-quarter to $192M.

Based on Raleigh Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.